• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE NAVALIGN COOK CELECT JUGULAR VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE NAVALIGN COOK CELECT JUGULAR VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Model Number G52909
Device Problems Structural Problem (2506); Device Tipped Over (2589); Detachment of Device or Device Component (2907); Unintended Movement (3026)
Patient Problems Anemia (1706); Chest Pain (1776); Death (1802); Hemorrhage/Bleeding (1888); Laceration(s) (1946); Pain (1994); Great Vessel Perforation (2152); Ambulation Difficulties (2544)
Event Type  Death  
Manufacturer Narrative
Manufacturers ref# (b)(4).Catalog# is unknown but referred to as cook celect filter.Reporter occupation: non-healthcare professional.Summary of investigational findings: the following allegations have been investigated: filter fracture, perforation of ivc and patient expired.Filter fracture has been reported and may be either symptomatic or asymptomatic.Fracture of a filter leg may be due to repetitive motion on a filter leg in an unusual, stressed position, such as a filter leg penetrating/perforating the ivc; or a filter leg being caught in a side branch (e.G., a renal vein).Other potential causes of filter fracture may include excessive force or manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Retrieval of a fractured filter or filter fragments (including embolized fragments) using endovascular techniques has been reported.Potential adverse events that may occur include, but are not limited to, the following: filter fracture, filter or filter fragment embolization, trauma to adjacent structures.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Unknown if the reported patient expired is directly related to the filter and unable to identify a corresponding failure mode at this point in time.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.Cook medical will continue to monitor for similar events.
 
Event Description
Description of event according to initial reporter: it is alleged that "[pt] received a cook celect filter on (b)(6) 2013.On or about the morning of (b)(6) 2018, [pt] was transported by ambulance to the hospital with complaints of severe chest and leg pain, dizziness, and shortness of breath.[pt] was admitted to the floor for treatment of potential pulmonary emboli, and a ct scan dedicated to the abdomen was ordered.While awaiting transfer from the emergency department to the floor, [pt]'s pain worsened and identified the pain as located in her kidney or flank area.It is alleged that "[pt] subsequently stopped breathing and a code was called.[pt] could not be resuscitated and was pronounced dead at approximately 4: 13 p.M.On (b)(6) 2018.During the autopsy, the pathologist noted approximately 1,000 ccs of blood in the peritoneal cavity and massive retroperitoneal hemorrhage, including an approximately 12"x10"x6" hematoma primarily located in the retroperitoneum.A fragment of one of the tines of the subject ivc filter was free in the clotted blood.The pathologist noted that the tines of the subject ivc filter had eroded and had lacerated and perforated [pt]'s distal inferior vena cava and proximal left common iliac vein, which was the location of the densest area of hemorrhage.The cause of death was determined to be "exsanguination due to laceration of the inferior vena cava and left common iliac vein as a result of a vascular filter." patient outcome: patient deceased.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Manufacturer ref (b)(4).Summary of investigational findings: investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.Filter fracture has been reported and may be either symptomatic or asymptomatic.Fracture of a filter leg may be due to repetitive motion on a filter leg in an unusual, stressed position, such as a filter leg penetrating/perforating the ivc; or a filter leg being caught in a side branch (e.G., a renal vein).Other potential causes of filter fracture may include excessive force or manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Retrieval of a fractured filter or filter fragments (including embolized fragments) using endovascular techniques has been reported.Potential adverse events that may occur include, but are not limited to, the following: filter fracture, filter or filter fragment embolization, trauma to adjacent structures.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Unknown if the reported severe chest and leg pain, dizziness,and shortness of breath are directly related to the filter and unable to identify a corresponding failure mode at this point in time.Unknown if the reported patient expired is directly related to the filter and unable to identify a corresponding failure mode at this point in time.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.Cook medical will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Manufacturer Narrative
Investigation: the following allegations have been investigated: ivc laceration, bleeding, migration, tilt, lacerated l common iliac vein, ambulation difficulty and suffering.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.The additional information regarding ivc laceration does not change the previous investigation results for vena cava perforation.Filter or filter fragment migration and (or) embolization (e.G., movement to the heart or lungs) has been reported.Filter or filter fragment movement has occurred in both the cranial and caudal direction and may be either symptomatic or asymptomatic.Potential causes may include filter placement in ivcs with diameters smaller or larger than those specified in these instructions for use; improper deployment; deployment into thrombus; dislodgement due to large thrombus burdens; and (or) excessive force or manipulations near an in situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: filter migration, trauma to adjacent structures.Filter tilt has been reported.Potential causes may include filter placement in ivcs with diameters larger than those specified in these instructions for use; improper deployment; manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter); and (or) a failed retrieval attempt.Excessive filter tilt may contribute to difficult or failed retrieval; vena cava wall penetration/perforation; and (or) result in loss of filter efficiency.Potential adverse events that may occur include, but are not limited to, the following: unacceptable filter tilt.Unknown if the reported lacerated l common iliac vein, ambulation difficulty and suffering are directly related to the filter and unable to identify a corresponding failure mode at this point in time.(b)(4) in lot.To date, no other complaints have been reported against the lot.The associated work order was reviewed.No related/relevant notes were documented.The device is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
Patient allegedly received an implant on (b)(6) 2013 via the right internal jugular vein due to bilateral pulmonary emboli (pe) and bilateral lower extremity deep vein thromboses (dvt).It is alleged the patient experienced device migration, tilt and fracture, vena cava perforation, bleeding, lacerated inferior vena cava and left common iliac vein, and wrongful death.It is also alleged and further noted the patient experienced "pain and suffering" as well as walking difficulty.Per the certificate of death dated (b)(6) 2018, immediate cause of death "exsanguination due to or as a consequence of laceration of the inferior vena cava and left common iliac vein due to or as a consequence of vascular filter".
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Manufacturers ref# (b)(4).Summary of investigational findings: on (b)(6) 2013 a celect filter was placed in the patient due to history of pe.The filter was placed in good position.On (b)(6) 2013 the patient had a ct due to history of anemia and pain.Images demonstrated a markedly enlarged myomatous uterus.Many of the fibroids was calcified.The dominant fibroid extends into the right upper abdomen adjacent to the gallbladder.It was noted that the filter was present.On (b)(6) 2018 the patient unfortunately died.Per death certificate dated (b)(6) 2018, immediate cause of death was exsanguination due to or consequence of laceration of the inferior vena cava and left common iliac vein due to or consequence of vascular filter.One piece of a secondary leg was returned.Based on the device evaluation it is unknown what caused the filter to fracture and allegedly to have lacerated the ivc.From the sparse information provided it is noted that the filter was placed correctly, and the patient had a ct scan 4 days after filter placement without any indication that the filter should have been placed/located incorrectly but the ct scan revealed an enlarged myomatous uterus.No information was provided from 4 days after placement until the patient unfortunately died.Without any information during that timeframe, it is impossible to say what caused the filter to fracture and ultimately the ivc to lacerate.Filter fracture has been reported and may be either symptomatic or asymptomatic.Fracture of a filter leg may be due to repetitive motion on a filter leg in an unusual, stressed position, such as a filter leg penetrating/perforating the ivc; or a filter leg being caught in a side branch (e.G., a renal vein).Other potential causes of filter fracture may include excessive force or manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Retrieval of a fractured filter or filter fragments (including embolized fragments) using endovascular techniques has been reported.Potential adverse events that may occur include, but are not limited to, the following: filter fracture, filter or filter fragment embolization, trauma to adjacent structures.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma.It was assessed that because any discovered non-conformances were properly dispositioned before qc release, there is evidence that the dhr was fully executed.In addition, no other lot related complaints have been received from the field.It is therefore concluded that there is no evidence that nonconforming product exists in house or in field.There are adequate controls in place to ensure the device was manufactured to specifications.Cook medical will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVALIGN COOK CELECT JUGULAR VENA CAVA FILTER SET
Type of Device
DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
Manufacturer (Section G)
WILLIAM COOK EUROPE
sandet 6, dk-4632
bjaeverskov
Manufacturer Contact
lissi walmann
sandet 6, dk-4632
bjaeverskov 
56868686
MDR Report Key10217082
MDR Text Key197093561
Report Number3002808486-2020-00666
Device Sequence Number1
Product Code DTK
UDI-Device Identifier10827002529097
UDI-Public(01)10827002529097(17)160121(10)E3035229
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K090140
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 02/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/21/2016
Device Model NumberG52909
Device Catalogue NumberIGTCFS-65-1-JUG-CELECT
Device Lot NumberE3035229
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Date Manufacturer Received02/15/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/21/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-